1. Home
  2. RIVN vs RDY Comparison

RIVN vs RDY Comparison

Compare RIVN & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIVN
  • RDY
  • Stock Information
  • Founded
  • RIVN 2009
  • RDY 1984
  • Country
  • RIVN United States
  • RDY India
  • Employees
  • RIVN N/A
  • RDY N/A
  • Industry
  • RIVN Auto Manufacturing
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • RIVN Consumer Discretionary
  • RDY Health Care
  • Exchange
  • RIVN Nasdaq
  • RDY Nasdaq
  • Market Cap
  • RIVN 15.6B
  • RDY 2.1B
  • IPO Year
  • RIVN 2021
  • RDY N/A
  • Fundamental
  • Price
  • RIVN $12.63
  • RDY $14.60
  • Analyst Decision
  • RIVN Hold
  • RDY Strong Buy
  • Analyst Count
  • RIVN 21
  • RDY 2
  • Target Price
  • RIVN $14.11
  • RDY $16.95
  • AVG Volume (30 Days)
  • RIVN 23.7M
  • RDY 1.4M
  • Earning Date
  • RIVN 08-05-2025
  • RDY 07-28-2025
  • Dividend Yield
  • RIVN N/A
  • RDY 0.56%
  • EPS Growth
  • RIVN N/A
  • RDY 1.47
  • EPS
  • RIVN N/A
  • RDY 0.79
  • Revenue
  • RIVN $5,006,000,000.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • RIVN $7.34
  • RDY $10.24
  • Revenue Next Year
  • RIVN $39.10
  • RDY N/A
  • P/E Ratio
  • RIVN N/A
  • RDY $18.44
  • Revenue Growth
  • RIVN 0.58
  • RDY 16.61
  • 52 Week Low
  • RIVN $9.50
  • RDY $12.26
  • 52 Week High
  • RIVN $18.49
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • RIVN 37.68
  • RDY 42.74
  • Support Level
  • RIVN $12.55
  • RDY $14.46
  • Resistance Level
  • RIVN $13.50
  • RDY $15.25
  • Average True Range (ATR)
  • RIVN 0.44
  • RDY 0.18
  • MACD
  • RIVN -0.05
  • RDY -0.10
  • Stochastic Oscillator
  • RIVN 10.97
  • RDY 16.40

About RIVN Rivian Automotive Inc.

Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues primarily from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: